Editorial: Case reports in hematological malignancies: 2022.
作者信息
Antar Ahmad, Szallasi Arpad, Imataki Osamu
机构信息
Department of Hematology-Oncology, Almoosa Specialist Hospital, Al-Ahsa, Saudi Arabia.
Faculty of Medicine, Semmelweis University, Budapest, Hungary.
出版信息
Front Oncol. 2023 Aug 21;13:1272547. doi: 10.3389/fonc.2023.1272547. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Case reports in hematological malignancies: 2022.社论：血液系统恶性肿瘤病例报告：2022年
Front Oncol. 2023 Aug 21;13:1272547. doi: 10.3389/fonc.2023.1272547. eCollection 2023.
2
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells.血液系统恶性肿瘤的过继性免疫治疗：嵌合抗原受体T细胞的现状与新见解
Blood Cells Mol Dis. 2016 Nov;62:49-63. doi: 10.1016/j.bcmd.2016.11.001. Epub 2016 Nov 10.
3
Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells.嵌合抗原受体 T 细胞靶向 B 细胞成熟抗原表达的血液系统恶性肿瘤。
Hum Gene Ther. 2018 May;29(5):585-601. doi: 10.1089/hum.2018.001.
4
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.嵌合抗原受体 T 细胞治疗后发生骨髓增生异常综合征，采用异体造血干细胞移植治疗。
Immunotherapy. 2023 Apr;15(6):401-407. doi: 10.2217/imt-2022-0205. Epub 2023 Mar 23.
5
CAR T-Cell Therapy in Hematological Malignancies.血液系统恶性肿瘤中的嵌合抗原受体T细胞疗法
Int J Mol Sci. 2021 Aug 20;22(16):8996. doi: 10.3390/ijms22168996.
6
Progress on CAR-T cell therapy for hematological malignancies.嵌合抗原受体 T 细胞疗法治疗血液系统恶性肿瘤的研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Apr 25;51(2):192-203. doi: 10.3724/zdxbyxb-2022-0055.
7
Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data.嵌合抗原受体T细胞疗法治疗B细胞血液系统恶性肿瘤：关键临床试验数据更新
Pharmaceutics. 2020 Feb 24;12(2):194. doi: 10.3390/pharmaceutics12020194.
8
Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study.血液恶性肿瘤患者嵌合抗原受体 T 细胞治疗后营养状况的改变：一项回顾性研究。
Support Care Cancer. 2022 Apr;30(4):3321-3327. doi: 10.1007/s00520-021-06639-2. Epub 2022 Jan 5.
9
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms.支持美国食品和药物管理局批准嵌合抗原受体 T 细胞疗法治疗血液恶性肿瘤的关键临床试验中纳入黑人参试者的情况。
JAMA Netw Open. 2022 Apr 1;5(4):e228161. doi: 10.1001/jamanetworkopen.2022.8161.
10
Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature.嵌合抗原受体 T 细胞（CAR T）治疗难治/复发 B 细胞淋巴瘤后发生的继发性髓系肿瘤：病例系列及文献复习。
Front Immunol. 2023 Jan 13;13:1063986. doi: 10.3389/fimmu.2022.1063986. eCollection 2022.
本文引用的文献
1
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版：髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
2
TEMPI syndrome associated with IgM monoclonal gammopathy.与IgM单克隆丙种球蛋白病相关的TEMPI综合征。
Blood. 2022 Feb 24;139(8):1254. doi: 10.1182/blood.2021014393.
3
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies.抢先性干扰素-α 治疗可预防异基因造血干细胞移植后急性髓系白血病患者的复发并改善其生存：两项注册研究的长期结果。
Front Immunol. 2022 Jan 28;13:757002. doi: 10.3389/fimmu.2022.757002. eCollection 2022.
4
Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.慢性中性粒细胞白血病：2022年诊断、基因组格局、预后及管理的最新进展
Am J Hematol. 2022 Apr;97(4):491-505. doi: 10.1002/ajh.26481. Epub 2022 Feb 9.
5
Neurologic Complications of Cancer Therapies.癌症治疗的神经系统并发症。
Curr Neurol Neurosci Rep. 2021 Nov 24;21(12):66. doi: 10.1007/s11910-021-01151-w.
6
A viral cause of APL.急性早幼粒细胞白血病的病毒病因
Blood. 2021 Nov 4;138(18):1653-1655. doi: 10.1182/blood.2021013630.
7
Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion.微小转矩病毒作为儿童急性早幼粒细胞白血病缺乏PML/RARA融合基因的一个病因。
Blood. 2021 Nov 4;138(18):1773-1777. doi: 10.1182/blood.2021011677.
8
Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab.利妥昔单抗治疗患者持续性 COVID-19 感染中，单克隆抗体的有效使用。
BMJ Case Rep. 2021 Aug 3;14(8):e243469. doi: 10.1136/bcr-2021-243469.
9
Current views on the genetic landscape and management of variant acute promyelocytic leukemia.关于变异型急性早幼粒细胞白血病的遗传格局与管理的当前观点。
Biomark Res. 2021 May 6;9(1):33. doi: 10.1186/s40364-021-00284-x.
10
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.甘露寡糖二酸治疗轻中度阿尔茨海默病的 36 周、多中心、随机、双盲、安慰剂对照、平行分组、3 期临床研究。
Alzheimers Res Ther. 2021 Mar 17;13(1):62. doi: 10.1186/s13195-021-00795-7.
Zotero 插件